Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric ...
Systemic lupus erythematosus is a lifelong condition that can cause irreversible damage to the major organs in the body, leading to life-threatening complications. These pivotal results are ...
RSV is the leading cause of infant hospitalization in the U.S.• Health officials urge vaccination for pregnant women, seniors ...
A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States, sending greater numbers of babies and toddlers to the hospital for professional care.
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II clinical study of AK0610, a ...
With symptoms including a cough, how can you know whether your child just has a cold or when it’s signs of RSV?
No difference in the risk for eczema or bronchiolitis were noted at 1 year of age with as needed use of acetaminophen or ibuprofen.
Compared with placebo, single-dose clesrovimab 105 mg reduced the risk for RSV-associated LRI and hospitalization in healthy infants.
The virus can lead to severe illnesses in babies and older adults, with a vaccine available to protect vulnerable groups - ...
A new study led by researchers at National Jewish Health has revealed that, while a wide range of viruses can cause lower ...
A new study led by researchers at National Jewish Health has revealed that, while a wide range of viruses can cause lower respiratory tract illnesses (LRIs) in infants, certain viruses and viral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback